<DOC>
	<DOC>NCT00143273</DOC>
	<brief_summary>To establish the optimal dose of lasofoxifene that is fully effective in increasing the BMD in postmenopausal Asian women.</brief_summary>
	<brief_title>Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>postmenopausal Asian women with osteoporosis defined by low BMD Metabolic bone disease, use of other osteoporosis drugs or drugs interering with normal bone metabolism</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>